AU507575B2 - Griseofulvin tablet - Google Patents

Griseofulvin tablet

Info

Publication number
AU507575B2
AU507575B2 AU86516/75A AU8651675A AU507575B2 AU 507575 B2 AU507575 B2 AU 507575B2 AU 86516/75 A AU86516/75 A AU 86516/75A AU 8651675 A AU8651675 A AU 8651675A AU 507575 B2 AU507575 B2 AU 507575B2
Authority
AU
Australia
Prior art keywords
tablet
griseofulvin
tablets
pvpp
polyethylene glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU86516/75A
Other languages
English (en)
Other versions
AU8651675A (en
Inventor
and Stoviak S. B Kornblum S. S.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Priority claimed from FR7534965A external-priority patent/FR2331327A2/fr
Publication of AU8651675A publication Critical patent/AU8651675A/en
Application granted granted Critical
Publication of AU507575B2 publication Critical patent/AU507575B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU86516/75A 1975-11-17 1975-11-11 Griseofulvin tablet Expired AU507575B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7534965A FR2331327A2 (fr) 1972-01-13 1975-11-17 Composition medicamenteuse solide a desagregation rapide

Publications (2)

Publication Number Publication Date
AU8651675A AU8651675A (en) 1977-05-19
AU507575B2 true AU507575B2 (en) 1980-02-21

Family

ID=9162473

Family Applications (1)

Application Number Title Priority Date Filing Date
AU86516/75A Expired AU507575B2 (en) 1975-11-17 1975-11-11 Griseofulvin tablet

Country Status (6)

Country Link
AT (1) AT348132B (de)
AU (1) AU507575B2 (de)
BE (1) BE835572A (de)
DE (1) DE2549740A1 (de)
GB (1) GB1504553A (de)
NL (1) NL7513230A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0230298A3 (en) * 1986-01-21 1988-01-20 Chugai Seiyaku Kabushiki Kaisha Stable solid preparation of thiol ester derivative

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
IE63321B1 (en) * 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system
ES2111065T5 (es) * 1991-04-16 2005-06-16 Nippon Shinyaku Company, Limited Procedimiento para producir una dispersion solida.
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
AU3574500A (en) * 1999-03-25 2000-10-16 Yuhan Corporation Rapidly disintegrable tablet for oral administration
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0230298A3 (en) * 1986-01-21 1988-01-20 Chugai Seiyaku Kabushiki Kaisha Stable solid preparation of thiol ester derivative
US4783334A (en) * 1986-01-21 1988-11-08 Chugai Seiyaku Kabushiki Kaisha Stable solid preparation of thiol ester derivative

Also Published As

Publication number Publication date
AU8651675A (en) 1977-05-19
GB1504553A (en) 1978-03-22
ATA848175A (de) 1978-06-15
AT348132B (de) 1979-01-25
NL7513230A (nl) 1977-05-16
DE2549740A1 (de) 1977-05-18
BE835572A (fr) 1976-05-13

Similar Documents

Publication Publication Date Title
AU510235B2 (en) Denture cleanser tablet
AU514195B2 (en) Dosage form
AU523209B2 (en) Tablet dispenser
AU1108376A (en) Polyhemoglobin
AU1025376A (en) Pourer-stopper
AU1006976A (en) Inhilator
AU1230276A (en) Amidinoureas
AU1230176A (en) Imidinoureas
AU1441776A (en) Thieno-pyridines
AU1373876A (en) Bottlecap
AU1775776A (en) Drawer construction
AU1667476A (en) Chroman-4-ones
AU1128976A (en) Magneto-alternator
AU1637076A (en) Banjo-shaped axle-casing
AU8651675A (en) Griseofulvin tablet
AU506320B2 (en) Size reduction
AU1417076A (en) Propargyl-2 phenylamino-2-impazolines
CA1030007A (en) Presses
AU1565576A (en) L- pyroglutamyl-l-prolinamide
AU505476B2 (en) Pharmaceutical composition
AU1520376A (en) Benzocycloheptathiophens
AU1408076A (en) Lysolipin Antibioties
AU1191776A (en) Fluoro-prostaglandins
ZA76829B (en) Tablet formulation
AU1393076A (en) Dihydromocimycin